| Impax Laboratories, Inc. (NASDAQ: IPXL) today reported its
strongest financial results in its history due to record sales from its
Global products sales channel.
|
| Neisseria meningitidis, the meningococcus, is a bacterium that can cause diseases with high fatality rates, and there has therefore been considerable concern that, like other bacteria, it might become resistant to antibiotics. But now a study from örebro |
